The manufacturer LEO laboratories LTD (T/A LEO Pharma) has today (27 January) recalled all unexpired stock of Picato gel over fears that it may cause skin malignancy.
The actinic keratosis treatment is also being recalled due to the suspension of the marketing authorisation of Picato, according to the Medicines and Healthcare Regulatory Agency (MHRA).
Related Article: Almost five million Pharmacy First consultations delivered in first year
Pharmacists have been advised to stop supplying the gel immediately and quarantine all remaining stock and return to the supplier, the MHRA said today.
They have also been advised to consider other treatment options for patients, and to urge those who have recently been prescribed Picato be vigilant for any skin lesions developing and to seek medical advice promptly should any occur.
Related Article: NPA 'decides against' collective action
The affected batches are:
Picato 150 mcg/g gel
Picato 500 mcg/g gel
Related Article: Government seeks pharmacists' views to underpin first-ever men’s health strategy
Batch Number | Expiry Date | Pack Size | First Distributed |
A69570A | Jan-20 | 3 x 0.47g tubes | 18-Apr-18 |
A69570B | Jan-20 | 3 x 0.47g tubes | 06-Jun-18 |
A72947A | Feb-20 | 3 x 0.47g tubes | 06-Jun-18 |
A75024A | Apr-20 | 3 x 0.47g tubes | 18-Jul-18 |
A78808A | May-20 | 3 x 0.47g tubes | 05-Sep-18 |
A80602B | Jun-20 | 3 x 0.47g tubes | 12-Sep-18 |
A80602A | Jun-20 | 3 x 0.47g tubes | 12-Sep-18 |
A89440A | Nov-20 | 3 x 0.47g tubes | 22-Jan-19 |
A92248A | Dec-20 | 3 x 0.47g tubes | 11-Feb-19 |
A98938A | Mar-21 | 3 x 0.47g tubes | 16-May-19 |
C01098A | Apr-21 | 3 x 0.47g tubes | 24-Jun-19 |
C10894A | Aug-21 | 3 x 0.47g tubes | 22-Oct-19 |
C14179A | Oct-21 | 3 x 0.47g tubes | 06-Dec-19 |
A76669A | Apr-20 | 2 x 0.47g tubes | 22-Aug-18 |
A88113A | Oct-20 | 2 x 0.47g tubes | 11-Dec-18 |
A98419A | Mar-21 | 2 x 0.47g tubes | 16-May-19 |
C03413A | May-21 | 2 x 0.47g tubes | 29-Aug-19 |
C11902A | Sep-21 | 2 x 0.47g tubes | 08-Nov-19 |
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.